Theralink Technologies named commercial provider of its patented Reverse Phase Protein Array (RPPA) technology for breast cancer patients

Media coverage

• Title	Theralink Technologies named commercial provider of its patented Reverse Phase Protein Array (RPPA) technology for breast cancer patients
  Media name/outlet	Impact Financial News
  Country/Territory	United Kingdom
  Date	23/02/21
  Persons	Emmanuel Petricoin